Ausgabe 1/2020
Symposium Title: Pharmaceutical Ethics
Inhalt (18 Artikel)
The Consent Form in the Chinese CRISPR Study: In Search of Ethical Gene Editing
David Shaw
A Continent Aflame: Ethical Lessons From the Australian Bushfire Disaster
Paul Komesaroff, Ian Kerridge
Lead Essay: Money, Equity and Access to Medicines
Narcyz Ghinea, Wendy Lipworth, Ian Kerridge
Why High Drug Pricing Is A Problem for Research Ethics
Spencer Phillips Hey
“Hunting Down My Son’s Killer”: New Roles of Patients in Treatment Discovery and Ethical Uncertainty
Marcello Ienca, Effy Vayena
Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective
Sharon Batt, Judy Butler, Olivia Shannon, Adriane Fugh-Berman
Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company
Ray Moynihan
Developing and Implementing new TB Technologies: Key Informants’ Perspectives on the Ethical Challenges
Renaud F. Boulanger, Ana Komparic, Angus Dawson, Ross E. G. Upshur, Diego S. Silva
Formulating an Ethics of Pharmaceutical Disinvestment
Jessica Pace, Tracey-Lea Laba, Marie-Paul Nisingizwe, Wendy Lipworth
Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity?
Narcyz Ghinea, Wendy Lipworth, Ian Kerridge
Pure Altruistic Gift and the Ethics of Transplant Medicine
Paweł Łuków
Deciding For When You Can’t Decide: The Medical Treatment Planning and Decisions Act 2016 (Vic)
Courtney Hempton, Neera Bhatia
Beyond Mendelian Genetics: Anticipatory Biomedical Ethics and Policy Implications for the Use of CRISPR Together with Gene Drive in Humans
Michael W. Nestor, Richard L. Wilson
Elective Impairment Minus Elective Disability: The Social Model of Disability and Body Integrity Identity Disorder
Richard B. Gibson